This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Hercules Technology (HTGC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Hercules Technology (HTGC) closed the most recent trading day at $13.49, moving -0.44% from the previous trading session.
Best Income Stocks to Buy for December 27th
by Zacks Equity Research
BHP, CCEP and HTGC made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 27, 2022.
New Strong Buy Stocks for December 21st
by Zacks Equity Research
BHP, HTGC, CAT, CMC and KNSL have been added to the Zacks Rank #1 (Strong Buy) List on December 21, 2022.
Best Income Stocks to Buy for December 21st
by Zacks Equity Research
BHP, HTGC and CAT made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 21, 2022.
Why Is Hercules Tech (HTGC) Down 4.7% Since Last Earnings Report?
by Zacks Equity Research
Hercules Tech (HTGC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
4 Reasons to Invest in Hercules Capital (HTGC) Stock Right Now
by Zacks Equity Research
Supported by strong fundamentals and good growth prospects, Hercules Capital (HTGC) stock looks like an attractive investment option now.
Zacks Industry Outlook Highlights Ares Capital, Main Street Capital and Hercules Capital
by Zacks Equity Research
Ares Capital, Main Street Capital and Hercules Capital have been highlighted in this Industry Outlook article.
Hercules Technology (HTGC) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
3 Stocks From the Promising SBIC & Commercial Finance Industry
by Swayta Shah
Higher rates, decent economic growth, robust asset quality and regulatory changes will keep aiding the Zacks SBIC & commercial finance industry players like Ares Capital (ARCC), Main Street Capital (MAIN) and Hercules Capital (HTGC).
Wall Street Analysts Believe Hercules Tech (HTGC) Could Rally 26%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Hercules Tech (HTGC) points to a 26.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
What's in Store for Prospect Capital (PSEC) in Q1 Earnings?
by Zacks Equity Research
Improvement in total investment income on higher interest rates is likely to have aided Prospect Capital's (PSEC) fiscal Q1 earnings.
Hercules Capital (HTGC) Up on Q3 Earnings Beat, Revenue Rise
by Zacks Equity Research
Hercules Capital (HTGC) records a rise in total investment income and expenses in the third quarter of 2022.
Hercules Technology (HTGC) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Hercules Tech (HTGC) delivered earnings and revenue surprises of 11.43% and 5.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Ares Capital (ARCC) Q3 Earnings Meet as Costs Dip, Stock Rises
by Zacks Equity Research
Ares Capital (ARCC) records a rise in total investment income and lower expenses in the third quarter of 2022.
Moody's (MCO) Down on Q3 Earnings Miss, Lower 2022 Outlook
by Zacks Equity Research
Muted global bond issuances substantially hurt Moody's (MCO) Q3 earnings. This, along with continued macroeconomic concerns, leads the company to revise the 2022 outlook downward.
Implied Volatility Surging for Hercules (HTGC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Hercules (HTGC) stock based on the movements in the options market lately.
Akero Therapeutics (AKRO) Up on Positive NASH Study Data
by Zacks Equity Research
Akero Therapeutics (AKRO) announces positive data from third cohort of its mid-stage study evaluating efruxifermin (EFX) in NASH. Stock up.
Zacks Industry Outlook Highlights Ares Capital, Golub Capital and Hercules Capital
by Zacks Equity Research
Ares Capital, Golub Capital and Hercules Capital have been highlighted in this Industry Outlook article.
3 Stocks From the Thriving SBIC & Commercial Finance Industry
by Swayta Shah
Higher rates, decent economic growth, robust asset quality and regulatory changes will keep aiding the Zacks SBIC & commercial finance industry players like Ares Capital (ARCC), Golub Capital (GBDC) and Hercules Capital (HTGC).
Robust Loan Originations Aid Hercules Capital (HTGC) Top Line
by Zacks Equity Research
Driven by the growing demand for customized financing, Hercules Capital's (HTGC) top line is expected to keep improving.
FS KKR Capital (FSK) Q2 Earnings Beat Despite Higher Expenses
by Zacks Equity Research
Rise in total investment income and decent portfolio activity support FS KKR Capital's (FSK) Q2 earnings.
Hercules Capital (HTGC) Q2 Earnings Miss, Revenues Rise Y/Y
by Zacks Equity Research
Hercules Capital (HTGC) records a rise in total investment income and expenses in the second quarter of 2022.
Hercules Technology (HTGC) Q2 Earnings Lag Estimates
by Zacks Equity Research
Hercules Tech (HTGC) delivered earnings and revenue surprises of -3.03% and 0.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Ares Capital (ARCC) Stock Rises on Q2 Earnings Beat, Costs Dip
by Zacks Equity Research
Ares Capital (ARCC) records a rise in total investment income and lower expenses in the second quarter of 2022.
Moody's (MCO) Tanks on Q2 Earnings Miss, Lower 2022 Outlook
by Zacks Equity Research
Weak issuance volume, macroeconomic headwinds and higher operating expenses hurt Moody's (MCO) Q2 earnings. Yet, acquisitions bolster Moody's Analytics segment's performance.